← All trials
NCT05298254
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 7, 2022
- Primary completion
- Jul 15, 2025
- Completion date
- May 12, 2026
- First posted
- Mar 28, 2022
- Last posted
- Dec 6, 2023
- Enrollment
- 332
- Arms / groups
- 13 / —
- Source
- AACT · ctgov ingestion
Sponsors
- GlaxoSmithKlineLead sponsor
- GlaxoSmithKlineStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.